XML 19 R25.htm IDEA: XBRL DOCUMENT v3.20.1
Stock-Based Awards (Tables)
12 Months Ended
Dec. 28, 2019
Stock-Based Awards  
Schedule Of Assumptions Used To Calculate Weighted-Average Grant Date Fair Value Of Common Stock Options Granted

 

 

 

 

 

 

 

 

 

 

Year Ended

 

 

 

December 28,

 

December 29,

 

 

    

2019

    

2018

 

Expected term (in years)

 

 

6.06

 

 

6.20

 

Expected volatility

 

 

108

%

 

108

%

Risk-free interest rate

 

 

1.92

%

 

2.75

%

Expected dividends

 

$

 —

 

$

 —

 

Weighted-average grant date fair value per share

 

$

0.29

 

$

0.21

 

 

Schedule Of Common Stock Options Activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

 

 

Weighted-

 

Remaining

 

Aggregate

 

 

 

Number of

 

Average

 

Contractual

 

Intrinsic

 

 

 

Shares

 

Exercise

 

Life

 

Value

 

 

    

(in thousands)

    

Price

    

(in years)

    

(in thousands)

 

Outstanding at December 29, 2018

 

 

8,186

 

$

1.18

 

 

5.88

 

$

223

 

Granted

 

 

790

 

$

0.35

 

 

 

 

 

 

 

Exercised

 

 

(175)

 

$

0.28

 

 

 

 

 

 

 

Expired or forfeited

 

 

(1,444)

 

$

0.89

 

 

 

 

 

 

 

Outstanding at December 28, 2019

 

 

7,357

 

$

1.17

 

 

5.54

 

$

127

 

Exercisable at December 28, 2019

 

 

5,799

 

$

1.37

 

 

4.69

 

$

49

 

Vested and expected to vest at December 28, 2019

 

 

7,097

 

$

1.20

 

 

5.41

 

$

114

 

 

Schedule Of Restricted Stock Awards

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

Average

 

 

Number of

 

Grant-Date

 

 

Shares

 

Fair Value

 

    

(in thousands)

    

per Share

Balance nonvested at December 29, 2018

 

 

525

 

$

0.25

Granted

 

 

3,727

 

$

0.55

Vested

 

 

(1,012)

 

$

0.47

Forfeited

 

 

(174)

 

$

0.54

Balance nonvested at December 28, 2019

 

 

3,066

 

$

0.52

 

Schedule of Stock-Based Compensation Expense

The following table summarizes the stock-based compensation expense by line item in the consolidated statements of operations (in thousands):

 

 

 

 

 

 

 

 

    

Year Ended

 

 

December 28,

 

December 29,

 

 

2019

 

2018

Cost of sales

 

$

26

 

$

26

Research and development

 

 

213

 

 

236

Selling, general and administrative

 

 

750

 

 

475

Total

 

$

989

 

$

737